Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice

Cited by papers we hold 14

• Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target · 2022
  No notice
• TGF-Beta as a Master Regulator of Diabetic Nephropathy · 2021
  No notice
• Signaling Pathways Involved in Diabetic Renal Fibrosis · 2021
  No notice
• Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT · 2021
  No notice
• Diverse Role of TGF-β in Kidney Disease · 2020
  No notice
• Transforming Growth Factor-Beta1 in Diabetic Kidney Disease · 2020
  No notice
• Antioxidant Effects and Mechanisms of Medicinal Plants and Their Bioactive Compounds for the Prevention and Treatment of Type 2 Diabetes: An Updated Review · 2020
  No notice
• Targeting TGF-β Signaling in Kidney Fibrosis · 2018
  No notice
• The role of klotho in chronic kidney disease · 2018
  No notice
• Pericytes, an overlooked player in vascular pathobiology · 2017
  No notice
• Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease · 2016
  No notice
• An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy · 2016
  No notice
• Inflammation in the pathogenesis of microvascular complications in diabetes · 2012
  No notice
• Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy · 2011
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.